WDAY delivered the day's cleanest beat. Workday guided Q2 sales to $2.635B, above the $2.628B consensus. Full-year guidance of $10.635B–$10.660B came in slightly below the $10.661B estimate but was broadly in line. The stock carries 13.8% short interest. Bears have not yet backed off — options activity expiring today keeps the name in play.
BIIB and DNLI absorbed a major blow. Their BIIB122 Parkinson's drug failed the Phase 2b LUMA trial on all endpoints. Denali carries 10.6% SI % FF. Put buyers moved quickly following the announcement.
IMAX shares popped on reports the company is exploring a sale. NFLX was named as a potential buyer. Call activity spiked sharply on the news.
Micro-cap shorts remain aggressive. ONCO saw SI % FF jump 156 percentage points in a week to 181%. and also saw dramatic short builds. Among larger names, and both ticked higher.
On the insider front, Bill Gates filed $74M in fresh purchases of RSG this week. A private equity firm offloaded $82M of RDW. MPWR CEO Michael Hsing filed $18.5M in sales.
Next week's calendar is heavy. CRM, MRVL, and SNPS report Tuesday. COST, ADSK, and DLTR follow Wednesday. Macro positioning ahead of those prints is adding short-term uncertainty across tech and retail.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
